Sadie R. Hallett

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

M. Malim, M. Shankar-Hari, S. Neil, 2021, Nature Microbiology.

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

M. Malim, M. Shankar-Hari, S. Neil, 2021, medRxiv.

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

M. Malim, Johnston J. Spencer, C. Graham, 2022, Cell Reports.

ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants

M. Malim, C. Graham, K. Doores, 2021, bioRxiv.

The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis

A. Gartland, M. Conte, A. Grigoriadis, 2023, bioRxiv.

LARP4A and LARP4B in cancer: The new kids on the block.

M. Conte, A. Grigoriadis, Sadie R. Hallett, 2023, The international journal of biochemistry & cell biology.